Sandbox:Preeti: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 5: | Line 5: | ||
{| | {| | ||
! rowspan="4" align="center" style="background:#4479BA; color: #FFFFFF;" + |Category | ! rowspan="4" align="center" style="background:#4479BA; color: #FFFFFF;" + |Category | ||
! | |||
! rowspan="4" align="center" style="background:#4479BA; color: #FFFFFF;" + |Disease | ! rowspan="4" align="center" style="background:#4479BA; color: #FFFFFF;" + |Disease | ||
! rowspan="4" align="center" style="background:#4479BA; color: #FFFFFF;" + |Etiology | ! rowspan="4" align="center" style="background:#4479BA; color: #FFFFFF;" + |Etiology | ||
Line 13: | Line 14: | ||
! rowspan="4" align="center" style="background:#4479BA; color: #FFFFFF;" + |Associated findings | ! rowspan="4" align="center" style="background:#4479BA; color: #FFFFFF;" + |Associated findings | ||
|- | |- | ||
! | |||
! colspan="9" align="center" style="background:#4479BA; color: #FFFFFF;" + |Lab findings | ! colspan="9" align="center" style="background:#4479BA; color: #FFFFFF;" + |Lab findings | ||
! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" + |Imaging | ! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" + |Imaging | ||
|- | |- | ||
! | |||
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Demography | ! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Demography | ||
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |History | ! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |History | ||
Line 28: | Line 31: | ||
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Other | ! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Other | ||
|- | |- | ||
! | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Inherited | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Inherited | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Acquired | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Acquired | ||
Line 44: | Line 48: | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Plt | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Plt | ||
|- | |- | ||
! colspan=" | ! colspan="30" align="left" style="background:#4479BA; color: #FFFFFF;" + |HL | ||
|- | |- | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" + | | ! align="center" style="background:#4479BA; color: #FFFFFF;" + | | ||
! | |||
! align="center" style="background:#DCDCDC;" + |Hodgkin's Lymphoma | ! align="center" style="background:#DCDCDC;" + |Hodgkin's Lymphoma | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 76: | Line 81: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
! colspan=" | ! colspan="30" align="left" style="background:#4479BA; color: #FFFFFF;" + |NHL | ||
|- | |- | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |B Cell Lymphoma | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |B Cell Lymphoma | ||
! | |||
! align="center" style="background:#DCDCDC;" + |Precursor B-cell lymphoblastic leukemia/lymphoma | ! align="center" style="background:#DCDCDC;" + |Precursor B-cell lymphoblastic leukemia/lymphoma | ||
| | | | ||
Line 111: | Line 117: | ||
|- | |- | ||
! | ! | ||
| | |||
|[[Follicular lymphoma]] | |[[Follicular lymphoma]] | ||
| | | | ||
Line 155: | Line 162: | ||
|- | |- | ||
! | ! | ||
| | |||
|Mantle cell lymphoma | |Mantle cell lymphoma | ||
| | | | ||
* | * [[CD5 (protein)|CD5]] positive antigen in pregerminal center of B-cell | ||
* [[Chromosomal translocation]] at '''t(11:14)''' | |||
** Over-express [[cyclin D1]] | |||
| | | | ||
| | | | ||
Line 164: | Line 173: | ||
| | | | ||
| | | | ||
* Stage IV disease | |||
* B symptoms, | |||
* Generalized lymphadenopathy | |||
* Abdominal distention | |||
* Fatigue | |||
* Night sweats | |||
* Weight Loss | |||
* Extranodal involvement of gastrointtestinal (GI) tract, lungs, and central nervous system (CNS) | |||
| | | | ||
| | | | ||
Line 169: | Line 186: | ||
| | | | ||
| | | | ||
* Generalized lymphadenopathy | |||
* Hepato-splenomegaly | |||
* Mental Retardation | |||
* Less commonly | |||
** Palpable masses in skin, breast, and salivary glands | |||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
|CBC | |||
* Anemia and cytopenias are secondary to bone marrow infiltration | |||
* Lymphocytosis > 4000/µL | |||
* Elevated LDH | |||
* | |||
| | | | ||
| | | | ||
Line 179: | Line 206: | ||
| | | | ||
| | | | ||
* CD5<sup>+</sup> | |||
* B-cell antigen positive | |||
** CD19 | |||
** CD20 | |||
** CD22 | |||
* Cyclin D1 is overexpressed. | |||
| | | | ||
* Germinal centers filled by small-to-medium atypical lymphocytes. | |||
* Nodular appearance may be evident from expansion of the mantle zone in 30-50% of patients early in the disease. | |||
| | | | ||
| | | | ||
Line 186: | Line 221: | ||
|- | |- | ||
! | ! | ||
| | |||
|Diffuse large B cell lymphoma | |Diffuse large B cell lymphoma | ||
| | | | ||
Line 235: | Line 271: | ||
|- | |- | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Category | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Category | ||
! | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Disease | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Disease | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Etiology | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Etiology | ||
Line 264: | Line 301: | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Associated findings | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Associated findings | ||
|- | |- | ||
! | |||
! | ! | ||
! align="center" style="background:#DCDCDC;" + |[[Burkitt lymphoma]] | ! align="center" style="background:#DCDCDC;" + |[[Burkitt lymphoma]] | ||
Line 326: | Line 364: | ||
|- | |- | ||
! | ! | ||
| | |||
|B cell chronic lymphocytic leukemia/small lymphocytic lymphoma | |B cell chronic lymphocytic leukemia/small lymphocytic lymphoma | ||
| | | | ||
Line 358: | Line 397: | ||
! | ! | ||
|Marginal zone lymphoma | |Marginal zone lymphoma | ||
|Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) type | |||
| | | | ||
* Mature B-cell Lymphoma | * Mature B-cell Lymphoma | ||
Line 387: | Line 427: | ||
| | | | ||
|- | |- | ||
| | | | ||
| | | | ||
|[[Splenic marginal zone lymphoma]] | |||
| | | | ||
* Clonal rearrangements of the [[immunoglobulin]] genes (heavy and light chains) . | |||
** Deletion 7q21-32 | |||
** Translocations of the CDK6 gene located at 7q21. | |||
| | | | ||
| | | | ||
Line 414: | Line 455: | ||
| | | | ||
| | | | ||
* [[CD20]] | |||
* [[CD79a]] | |||
| | | | ||
* [[B-cells]] replace the normal [[white pulp]] of the [[spleen]]. | |||
* The neoplastic cells compromise | |||
** Small [[lymphocytes]] | |||
** Transformed blasts | |||
* S[[Sinus|inus]] invasion | |||
* Epithelial histocytes | |||
* Plasmacytic differentiation of neoplastic cells. | |||
* '''Splenic Hilar Lymph Nodes''' | |||
** Involved hilar [[lymph nodes]] adjacent to the [[spleen]] show an effaced architecture without preservation of the [[marginal zone]] seen in the spleen | |||
* '''Bone Marrow Biopsy''' | |||
** Splenic marginal zone lymphoma in [[bone marrow]] displays a nodular pattern with morphology similar to what is observed in the splenic [[hilar]] [[lymph nodes]]. | |||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
|- | |||
| | | | ||
| | | | ||
|[[Nodal marginal zone B-cell lymphoma]] | |[[Nodal marginal zone B-cell lymphoma]] | ||
| | | | ||
Line 523: | Line 523: | ||
| | | | ||
|- | |- | ||
| | | | ||
| | |||
* | |Lymphoplasmacytic lymphoma (Waldenstrom’s macroglobulinemia) | ||
| | |||
* Mature B-cell Lymphoma | |||
| | | | ||
| | | | ||
Line 549: | Line 549: | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
Line 568: | Line 555: | ||
| | | | ||
|- | |- | ||
| | |||
| | |||
|[[Hairy cell leukemia]] | |[[Hairy cell leukemia]] | ||
| | | | ||
Line 629: | Line 618: | ||
| | | | ||
|- | |- | ||
| | | | ||
| | | | ||
|Precursor T-cell lymphoblastic leukemia/lymphoma | |||
| | | | ||
* '''Precursor T-cell Lymphomas''' | |||
| | | | ||
| | | | ||
Line 687: | Line 652: | ||
| | | | ||
|- | |- | ||
| | | | ||
| | | | ||
| | |Adult T cell leukemia/lymphoma | ||
| | | | ||
| | | | ||
Line 745: | Line 683: | ||
| | | | ||
|- | |- | ||
| | |T cell lymphoma | ||
| | | | ||
| | |Anaplastic large cell lymphoma | ||
| | | | ||
| | | | ||
Line 803: | Line 714: | ||
| | | | ||
|- | |- | ||
| | | | ||
|Cutaneous T-cell lymphoma | |||
|[[Mycosis fungoides]] / [[Sézary syndrome]] | |||
| | | | ||
* The [[tumor]] [[Cell (biology)|cells]] originate from [[memory T cells]] or [[skin]] homing [[CD4+ T cells]] expressing [[cutaneous]] [[lymphocyte]] [[antigen]] (CLA) and [[chemokine]] [[receptors]] [[CCR4]]<nowiki/>and CCR7. | |||
* It is understood that cutaneous t cell lymphoma (maycosis fungoides, Sezary sydrome ) is the result of malignant T cell that derived from a mature CD41 CD45RO1 memory T cells. | |||
| | | | ||
| | | | ||
Line 811: | Line 725: | ||
| | | | ||
| | | | ||
* [[Epidermis (skin)|Epidermal]] [[atrophy]] or poikiloderma | |||
* Generalized [[itching]]([[pruritus]]) | |||
* [[Pain]] in the affected area of the skin. | |||
* [[Insomnia]] | |||
* Red ([[erythematous]]) patches scattered over the [[skin]] of the [[trunk]] and the [[extremities]] | |||
* [[Weight loss]] | |||
* [[Lymphadenopathy]] | |||
* [[Malaise]] and [[fatigue]] | |||
* [[Anemia]] | |||
* May progress to [[Sezary syndrome]] (Skin involvement plus hematogenous dissemination) | |||
| | | | ||
| | | | ||
Line 816: | Line 741: | ||
| | | | ||
| | | | ||
* Cutaneous manifestaions | |||
| | | | ||
| | | | ||
Line 861: | Line 759: | ||
| | | | ||
|- | |- | ||
| | | | ||
| | | rowspan="6" |Peripheral T-cell lymphoma | ||
| | |Subcutaneous panniculitis-like T-cell lymphoma | ||
|- | |||
| | | | ||
| | | | ||
Line 919: | Line 790: | ||
| | | | ||
|- | |- | ||
| | | | ||
|- | |Hepatosplenic gamma-delta T-cell lymphoma | ||
| | | | ||
| | | | ||
Line 960: | Line 803: | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
Line 1,283: | Line 821: | ||
|- | |- | ||
| | | | ||
|Enteropathy-type intestinal T-cell lymphoma | |||
| | | | ||
| | | | ||
Line 1,312: | Line 851: | ||
|- | |- | ||
| | | | ||
|Extranodal T-cell lymphoma, nasal type | |||
| | | | ||
| | | | ||
Line 1,341: | Line 881: | ||
|- | |- | ||
| | | | ||
|Angioimmunoblastic T-cell lymphoma | |||
| | | | ||
| | | | ||
Line 1,369: | Line 910: | ||
| | | | ||
|- | |- | ||
| | | | ||
| | |Peripheral T-cell lymphoma, unspecified | ||
| | | | ||
| | | |
Revision as of 20:11, 28 December 2018
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Preeti Singh, M.B.B.S.[2]
Category | Disease | Etiology | Mechanism | Clinical manifestations | Paraclinical findings | Gold standard | Associated findings | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lab findings | Imaging | ||||||||||||||||||||||||||||
Demography | History | Symptoms | Signs | CBC | PBS | LFT | PT/PTT | Immunochemistry | Histopathology | Other | |||||||||||||||||||
Inherited | Acquired | Constitutional symptoms | Rash | Abdominal pain | Diarrhea | V/S | Mass | LAP | Hepatosplenomegaly | Arthritis | Other | WBC | Hb | Plt | |||||||||||||||
HL | |||||||||||||||||||||||||||||
Hodgkin's Lymphoma | |||||||||||||||||||||||||||||
NHL | |||||||||||||||||||||||||||||
B Cell Lymphoma | Precursor B-cell lymphoblastic leukemia/lymphoma |
|
|||||||||||||||||||||||||||
Follicular lymphoma |
|
+ | + |
|
|
+ | |||||||||||||||||||||||
Mantle cell lymphoma |
|
|
|
CBC
|
|
|
|||||||||||||||||||||||
Diffuse large B cell lymphoma |
|
|
|
↓ | ↓ | Nl to ↓ |
|
Centroblastic
Immunoblastic
Anaplastic:
|
|
||||||||||||||||||||
Category | Disease | Etiology | Inherited | Acquired | Demography | History | Constitutional symptoms | Rash | Abdominal pain | Diarrhea | V/S | Mass | LAP | Hepatosplenomegaly | Arthritis | Other | WBC | Hb | Plt | PBS | LFT | PT/PTT | Immunochemistry | Histopathology | Other lab findings | Imaging | Gold standard | Associated findings | |
Burkitt lymphoma |
|
|
|
|
|
||||||||||||||||||||||||
B cell chronic lymphocytic leukemia/small lymphocytic lymphoma |
|
||||||||||||||||||||||||||||
Marginal zone lymphoma | Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) type |
|
|||||||||||||||||||||||||||
Splenic marginal zone lymphoma |
|
|
|||||||||||||||||||||||||||
Nodal marginal zone B-cell lymphoma |
|
|
|
|
|||||||||||||||||||||||||
Lymphoplasmacytic lymphoma (Waldenstrom’s macroglobulinemia) |
|
||||||||||||||||||||||||||||
Hairy cell leukemia |
|
|
|
||||||||||||||||||||||||||
Precursor T-cell lymphoblastic leukemia/lymphoma |
|
||||||||||||||||||||||||||||
Adult T cell leukemia/lymphoma | |||||||||||||||||||||||||||||
T cell lymphoma | Anaplastic large cell lymphoma | ||||||||||||||||||||||||||||
Cutaneous T-cell lymphoma | Mycosis fungoides / Sézary syndrome |
|
|
|
|||||||||||||||||||||||||
Peripheral T-cell lymphoma | Subcutaneous panniculitis-like T-cell lymphoma | ||||||||||||||||||||||||||||
Hepatosplenic gamma-delta T-cell lymphoma | |||||||||||||||||||||||||||||
Enteropathy-type intestinal T-cell lymphoma | |||||||||||||||||||||||||||||
Extranodal T-cell lymphoma, nasal type | |||||||||||||||||||||||||||||
Angioimmunoblastic T-cell lymphoma | |||||||||||||||||||||||||||||
Peripheral T-cell lymphoma, unspecified |